BioCorRx (BICX) Net Cash Flow Growth (1y) (2011 - 2026)
BioCorRx (BICX) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 156.92% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -113.10% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -304.79% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | -90.20% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | -440.94% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 27.26% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | -1,475.56% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | -69.26% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 342.67% |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213.55% |
| Dec 31, 2025 | -268.66% |
| Sep 30, 2025 | 2,224.66% |
| Jun 30, 2025 | 194.62% |
| Mar 31, 2025 | -278.18% |
| Dec 31, 2024 | 196.44% |
| Sep 30, 2024 | 79.77% |
| Jun 30, 2024 | -1,352.53% |
| Mar 31, 2024 | -73.45% |
| Dec 31, 2023 | -1,892.90% |
| Sep 30, 2023 | 14.68% |
| Jun 30, 2023 | 93.72% |
| Mar 31, 2023 | 6.08% |
| Dec 31, 2022 | 100.77% |
| Sep 30, 2022 | -213.32% |
| Jun 30, 2022 | 91.57% |
| Mar 31, 2022 | -90.34% |
| Dec 31, 2021 | -91.66% |
| Sep 30, 2021 | 108.01% |
| Jun 30, 2021 | -138.14% |